140
Participants
Start Date
December 31, 2004
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
tolvaptan
Guthrie Foundation, Syre
UNC Heart Failure Program, Chapel Hill
ACRI, Atlanta
Cardiovascular Center at Shands Jacksonville, Jacksonville
Broward General Medical Center, Fort Lauderdale
Tampa General Hospital, Tampa
Oracle Research, A Div of the Heart Center, Huntsville
Cleveland VA Medical Center, Cleveland
University of Cincinnati, Cincinnati
Henry Ford Hospital, Detroit
University of Iowa Health Care, Iowa City
Loyola University of Chicago, Maywood
Northwestern University, Chicago
Robert Rush University Medical Center, Chicago
Washington University School of Medicine, St Louis
Heart Consultants, PC, Omaha
Cardiologist Institute, Slidell
Medical Research Institute Louisiana Heart Hospital, Slidell
Texas Heart Institute, Houston
Southeast Texas Clinical Research, Orange
Olive View-UCLA Medical Center, Sylmar
Merced Heart Associates, Merced
Oregon Health Sciences University, Portland
Primary Cardiology Associates, Ayer
U-MASS Memorial Medical Center, Worchester
University of Medicine and Dentistry, Newark
Spitalul Clinic Urgenta, Bucharest
Institutul de Boli Cardiovasculare, Bucharest
"Institutul de Boli CardiovasculareProf. Dr. C.C. Illiescu", Bucharest
Institutul Inimii, Judetul Cluj
Institutul de Boli Cardiovasculare si Transplant, Judetul Mures
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY